* 논문 및 저서
Kim JW, Choi SH. Re: Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel to treat synchronous peritoneal carcinomatosis from gastric cancer: Results from a Chinese center, Eur J Surg Oncol (2016). Eur J Surg Oncol. 2016 Nov;42(11):1760-1761. doi: 10.1016/j.ejso.2016.06.406.
Seol SY, Kim C, Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Overexpression of Endoplasmic Reticulum Oxidoreductin 1-α (ERO1L) Is Associated with Poor Prognosis of Gastric Cancer. Cancer Res Treat. 2016 Oct;48(4):1196-1209.
Lee YJ, Kim JH, Park JJ, Youn YH, Park H, Kim JW, Choi SH, Noh SH. The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy? PLoS One. 2016 Oct 14;11(10):e0164339. doi: 10.1371/journal.pone.0164339.
Kim HW, Kim JH, Lim BJ, Kim H, Kim H, Park JJ, Youn YH, Park H, Noh SH, Kim JW, Choi SH. Erratum to: Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer. Ann Surg Oncol. 2016 Aug 5.
Kim HW, Kim JH, Lim BJ, Kim H, Kim H, Park JJ, Youn YH, Park H, Noh SH, Kim JW, Choi SH. Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer. Ann Surg Oncol. 2016 Jul 28
Huh CW, Jung DH, Kim H, Kim H, Youn YH, Park H, Kim JW, Choi SH, Noh SH, Kim JH. Clinicopathologic features of gastric carcinoma with lymphoid stroma in early gastric cancer. J Surg Oncol. 2016 Jul 22. doi: 10.1002/jso.24385.
Nakagawa M, Choi YY, An JY, Hong JH, Kim JW, Kim HI, Cheong JH, Hyung WJ, Choi SH, Noh SH. Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System. Ann Surg Oncol. 2016 Jul 1.
Woo Y, Son T, Song K, Okumura N, Hu Y, Cho GS, Kim JW, Choi SH, Noh SH, Hyung WJ. A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma: Development and Validation Using Asian Databases. Ann Surg. 2016 Jul;264(1):114-20. doi: 10.1097/SLA.0000000000001523.
Yoon HJ, Kim YH, Kim JH, Kim H, Kim H, Park JJ, Youn YH, Park H, Kim JW, Hyung WJ, Noh SH, Choi SH. Are new criteria for mixed histology necessary for endoscopic resection in early gastric cancer? Pathol Res Pract. 2016 May;212(5):410-4. doi: 10.1016/j.prp.2016.02.013.
Kim HW, Lee YJ, Kim JH, Park JJ, Youn YH, Park H, Kim JW, Choi SH, Noh SH. The role of tumor size in surgical decision making after endoscopic resection for early gastric cancer. Surg Endosc. 2016 Jul;30(7):2799-803. doi: 10.1007/s00464-015-4556-4.
Kang DW, Kim JW, Choi SH. Microflora of upper gastrointestinal tract in gastric cancer patients. Korean J Clin Oncol. 2015; 11(2): 87-94
Cho JH, Lim JY, Choi AR, Choi SM, Kim JW, Choi SH, Cho JY. Comparison of Surgery Plus Chemotherapy and Palliative Chemotherapy Alone for Advanced Gastric Cancer with Krukenberg Tumor. Cancer Res Treat. 2015 Oct;47(4):697-705. doi: 10.4143/crt.2013.175.
Im MH, Kim JW, Kim WS, Kim JH, Youn YH, Park H, Choi SH. The impact of esophageal reflux-induced symptoms on quality of life after gastrectomy in patients with gastric cancer. J Gastric Cancer. 2014 Mar;14(1):15-22. doi: 10.5230/jgc.2014.14.1.15.
Son T, Hyung WJ, Kim JW, Kim HI, An JY, Cheong JH, Choi SH, Noh SH. Anatomic extent of metastatic lymph nodes: still important for gastric cancer prognosis. Ann Surg Oncol. 2014 Mar;21(3):899-907. doi: 10.1245/s10434-013-3403-x.
Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Lee JS, Cho JY. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol. 2013 Nov 7;19(41):7078-88. doi: 10.3748/wjg.v19.i41.7078.
Kim MJ, Kim JH, Lee YC, Kim JW, Choi SH, Hyung WJ, Noh SH, Youn YH, Park H, Lee SI. Is there an optimal surgery time after endoscopic resection in early gastric cancer? Ann Surg Oncol. 2014 Jan;21(1):232-9. doi: 10.1245/s10434-013-3299-5.
Kim BH, Hong SW, Kim JW, Choi SH, Yoon SO. Oncologic safety of pylorus-preserving gastrectomy in the aspect of micrometastasis in lymph nodes at stations 5 and 6. Ann Surg Oncol. 2014 Feb;21(2):533-8. doi: 10.1245/s10434-013-3252-7.
Jung da H, Park YM, Kim JH, Lee YC, Youn YH, Park H, Lee SI, Kim JW, Choi SH, Hyung WJ, Noh SH. Clinical implication of endoscopic gross appearance in early gastric cancer: revisited. Surg Endosc. 2013 Oct;27(10):3690-5. doi: 10.1007/s00464-013-2947-y. Epub 2013 Apr 16.
Kim JW, Kim WS, Cheong JH, Hyung WJ, Choi SH, Noh SH. Safety and Efficacy of Fast-track Surgery in Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Clinical Trial World J Surg. 2012 Dec;36(12):2879-87. doi: 10.1007/s00268-012-1741-7.
Ihn K, Hyung WJ, Kim HI, An JY, Kim JW, Cheong JH, Yoon DS, Choi SH, Noh SH. Treatment Results of Small Intestinal Gastrointestinal Stromal Tumors Less than 10 cm in Diameter: A Comparison between Laparoscopy and Open Surgery. J Gastric Cancer. 2012 Dec;12(4):243-8. doi: 10.5230/jgc.2012.12.4.243. Epub 2012 Dec 31.
Lim JY, Yoon SO, Hong SW, Kim JW, Choi SH, Cho JY. Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. World J Gastroenterol. 2012 Oct 21;18(39):5581-8. doi: 10.3748/wjg.v18.i39.5581.
Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Cho JY. Overexpression of the M2 isoform of pyruvate kinase is an adverse prognostic factor for signet ring cell gastric cancer. World J Gastroenterol. 2012 Aug 14;18(30):4037-43. doi: 10.3748/wjg.v18.i30.4037.
Kim WS, Kim JW, Ahn CW, Choi SH. Resolution of type 2 diabetes after gastrectomy for gastric cancer with long limb Roux-en Y reconstruction: a prospective pilot study. J Korean Surg Soc. 2013 Feb;84(2):88-93. doi: 10.4174/jkss.2013.84.2.88. Epub 2013 Jan 29.
Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol. 2012 Jan 7;18(1):49-54.
Pak KH, Hyung WJ, Son T, Obama K, Woo Y, Kim HI, An JY, Kim JW, Cheong JH, Choi SH, Noh SH. Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute. Surg Endosc. 2012 Jan;26(1):130-6. Epub 2011 Jul 26.
Park JS, Lim JY, Park SK, Kim MK, Ko HS, Yoon SO, Kim JW, Choi SH, Cho JY. Prognostic factors of second and third line chemotherapy using 5-fu with platinum, irinotecan, and taxane for advanced gastric cancer. Cancer Res Treat. 2011 Dec;43(4):236-43. doi: 10.4143/crt.2011.43.4.236. Epub 2011 Dec 27.
Kong SH, Lee HJ, Ahn HS, Kim JW, Kim WH, Lee KU, Yang HK. Stage Migration Effect on Survival in Gastric Cancer Surgery with Extended Lymphadenectomy: The Reappraisal of Positive Lymph Node Ratio as a Proper N-Staging. Ann Surg. 2011 May 13. [Epub ahead of print]
Kim JW, Kong SH, Kim MA, Kim WH, Lee HJ, Lee KU, Yang HK. Transverse mesocolon invasion in advanced gastric cancer: should we reconsider current T staging? Ann Surg Oncol. 2011 May;18(5):1274-81. Epub 2011 Jan 8.
Kong SH, Yoo MW, Kim JW, Lee HJ, Kim WH, Lee KU, Yang HK. Validation of limited lymphadenectomy for lower-third gastric cancer based on depth of tumour invasion. Br J Surg. 2011 Jan;98(1):65-72. doi: 10.1002/bjs.7266. Epub 2010 Oct 15.
Kong SH, Kim JW, Lee HJ, Kim WH, Lee KU, Yang HK. Reverse double-stapling end-to-end esophagogastrostomy in proximal gastrectomy. Dig Surg. 2010 Aug;27(3):170-4. Epub 2010 Jun 22.
Kim JW, Yoon H, Kong SH, Kim JS, Paeng JC, Lee HJ, Lee KU, Yang HK. Analysis of esophageal reflux after proximal gastrectomy measured by wireless ambu latory 24-hr esophageal pH monitoring and TC-99m diisopropyliminodiacetic acid (DISIDA) scan. J Surg Oncol. 2010 Jun 1;101(7):626-33.
Kong SH, Kim JW, Lee HJ, Kim WH, Lee KU, Yang HK. The safety of the dissection of lymph node stations 5 and 6 in pylorus-preserving gastrectomy. Ann Surg Oncol. 2009 Dec;16(12):3252-8.
Lee DS, Yang HK, Kim JW, Yook JW, Jeon SH, Kang SH, Kim YJ. Identifying the risk factors through the development of a predictive model for gastric cancer in South Korea. Cancer Nurs. 2009 Mar-Apr;32(2):135-42.
* 저서
대한외과대사영양학회(저자참여), 임상 대사 영양학, 도서출판 가본의학 2016년 3월
비만대사외과학 교과서 (군자출판사, 대한비만외과대사학회) 공저